The Role of NRF2 in Bone Metabolism - Friend or Foe?

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Mar 14

PMID 35282459

Authors

Jie Han

Kuan Yang

Jinyang An

Na Jiang

Songbo Fu

Xulei Tang

Affiliations

Soon will be listed here.

Abstract

Bone metabolism is closely related to oxidative stress. As one of the core regulatory factors of oxidative stress, NRF2 itself and its regulation of oxidative stress are both involved in bone metabolism. NRF2 plays an important and controversial role in the regulation of bone homeostasis in osteoblasts, osteoclasts and other bone cells. The role of NRF2 in bone is complex and affected by several factors, such as its expression levels, age, sex, the presence of various physiological and pathological conditions, as well as its interaction with certains transcription factors that maintain the normal physiological function of the bone tissue. The properties of NRF2 agonists have protective effects on the survival of osteogenic cells, including osteoblasts, osteocytes and stem cells. Activation of NRF2 directly inhibits osteoclast differentiation by resisting oxidative stress. The effects of NRF2 inhibition and hyperactivation on animal skeleton are still controversial, the majority of the studies suggest that the presence of NRF2 is indispensable for the acquisition and maintenance of bone mass, as well as the protection of bone mass under various stress conditions. More studies show that hyperactivation of NRF2 may cause damage to bone formation, while moderate activation of NRF2 promotes increased bone mass. In addition, the effects of NRF2 on the bone phenotype are characterized by sexual dimorphism. The efficacy of NRF2-activated drugs for bone protection and maintenance has been verified in a large number of and studies. Additional research on the role of NRF2 in bone metabolism will provide novel targets for the etiology and treatment of osteoporosis.

Citing Articles

Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways.

Saenjum C, Thim-Uam A, Khonthun C, Oonlao P, Nuntaboon P, Surh Y Inflammopharmacology. 2025; 33(1):381-399.

PMID: 39806052 PMC: 11799051. DOI: 10.1007/s10787-024-01634-5.

Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation.

Huang F, Wang Y, Liu J, Cheng Y, Zhang X, Jiang H J Orthop Surg Res. 2024; 19(1):855.

PMID: 39702357 PMC: 11658297. DOI: 10.1186/s13018-024-05320-8.

Inhibition of insulin degrading enzyme suppresses osteoclast hyperactivity via enhancing Nrf2-dependent antioxidant response in glucocorticoid-induced osteonecrosis of the femoral head.

Yuan T, Wang H, Wang Y, Dong S, Ge J, Li Z Mol Med. 2024; 30(1):111.

PMID: 39085816 PMC: 11292917. DOI: 10.1186/s10020-024-00880-1.

A Synthetic Small Molecule, LGM2605: A Promising Modulator of Increased Pro-Inflammatory Cytokine and Osteoclast Differentiation by Cytolethal Distending Toxin.

Kim T, MacElroy A, Defreitas A, Shenker B, Boesze-Battaglia K Dent J (Basel). 2024; 12(7).

PMID: 39056982 PMC: 11276599. DOI: 10.3390/dj12070195.

New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation.

Zhang L, Xu L, Tang F, Liu D, Zhao X, Zhang J J Pharm Anal. 2024; 14(6):100930.

PMID: 39005843 PMC: 11245930. DOI: 10.1016/j.jpha.2023.12.020.

References

Park C, Lee Y, Kim K, Lee Z, Joo M, Kim H . Nrf2 is a novel regulator of bone acquisition. Bone. 2014; 63:36-46. DOI: 10.1016/j.bone.2014.01.025. View

Clarke B . Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008; 3 Suppl 3:S131-9. PMC: 3152283. DOI: 10.2215/CJN.04151206. View

Tian X, Cong F, Guo H, Fan J, Chao G, Song T . Downregulation of Bach1 protects osteoblasts against hydrogen peroxide-induced oxidative damage in vitro by enhancing the activation of Nrf2/ARE signaling. Chem Biol Interact. 2019; 309:108706. DOI: 10.1016/j.cbi.2019.06.019. View

Matsuo K, Ray N . Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. Keio J Med. 2004; 53(2):78-84. DOI: 10.2302/kjm.53.78. View

Siddiqui J, Partridge N . Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology (Bethesda). 2016; 31(3):233-45. PMC: 6734079. DOI: 10.1152/physiol.00061.2014. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

Taguchi K, Fujikawa N, Komatsu M, Ishii T, Unno M, Akaike T . Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A. 2012; 109(34):13561-6. PMC: 3427110. DOI: 10.1073/pnas.1121572109. View

Li X, Zhan J, Hou Y, Hou Y, Chen S, Luo D . Coenzyme Q10 Regulation of Apoptosis and Oxidative Stress in HO Induced BMSC Death by Modulating the Nrf-2/NQO-1 Signaling Pathway and Its Application in a Model of Spinal Cord Injury. Oxid Med Cell Longev. 2020; 2019:6493081. PMC: 6930770. DOI: 10.1155/2019/6493081. View

Menale C, Robinson L, Palagano E, Rigoni R, Erreni M, Almarza A . Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss. J Bone Miner Res. 2019; 34(11):2133-2148. PMC: 7203631. DOI: 10.1002/jbmr.3829. View

10.

Zhang S, Li D, Yang J, Yan T . Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway. Cell Stress Chaperones. 2015; 20(4):621-9. PMC: 4463920. DOI: 10.1007/s12192-015-0585-0. View

11.

Schreck R, Rieber P, Baeuerle P . Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991; 10(8):2247-58. PMC: 452914. DOI: 10.1002/j.1460-2075.1991.tb07761.x. View

12.

Suh K, Chon S, Choi E . Luteolin alleviates methylglyoxal-induced cytotoxicity in osteoblastic MC3T3-E1 cells. Cytotechnology. 2016; 68(6):2539-2552. PMC: 5101326. DOI: 10.1007/s10616-016-9977-y. View

13.

Yamamoto M, Kensler T, Motohashi H . The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol Rev. 2018; 98(3):1169-1203. PMC: 9762786. DOI: 10.1152/physrev.00023.2017. View

14.

Xu Y, Guan J, Xu J, Chen S, Sun G . Z-Guggulsterone attenuates glucocorticoid-induced osteoporosis through activation of Nrf2/HO-1 signaling. Life Sci. 2019; 224:58-66. DOI: 10.1016/j.lfs.2019.03.051. View

15.

Park J, Lee N, Lee S . Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation. Mol Cells. 2017; 40(10):706-713. PMC: 5682248. DOI: 10.14348/molcells.2017.0225. View

16.

Lippross S, Beckmann R, Streubesand N, Ayub F, Tohidnezhad M, Campbell G . Nrf2 deficiency impairs fracture healing in mice. Calcif Tissue Int. 2014; 95(4):349-61. DOI: 10.1007/s00223-014-9900-5. View

17.

Kanzaki H, Shinohara F, Itohiya K, Yamaguchi Y, Katsumata Y, Matsuzawa M . RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice. FASEB J. 2016; 31(2):781-792. DOI: 10.1096/fj.201600826R. View

18.

Xu A, Yang Y, Shao Y, Wu M, Sun Y . Activation of cannabinoid receptor type 2-induced osteogenic differentiation involves autophagy induction and p62-mediated Nrf2 deactivation. Cell Commun Signal. 2020; 18(1):9. PMC: 6964093. DOI: 10.1186/s12964-020-0512-6. View

19.

Khan N, Ahmad I, Haqqi T . Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6K-P90RSK signaling axis. Free Radic Biol Med. 2018; 116:159-171. PMC: 5815915. DOI: 10.1016/j.freeradbiomed.2018.01.013. View

20.

Silva-Islas C, Maldonado P . Canonical and non-canonical mechanisms of Nrf2 activation. Pharmacol Res. 2018; 134:92-99. DOI: 10.1016/j.phrs.2018.06.013. View